Dermatology Diagnostics and Therapeutics Market by Diagnostic Products (Dermatoscopes, Imaging, Microscopes, and Trichoscopes), Therapeutic Products (Antibacterial, Antifungal, Antiviral, Biological, Corticosteroids, Immunosuppressant, and Retinoids) and Product Pipeline (Clinical Phase 1, 2 and 3) and Forecast 2017-2021

Dermatology Diagnostics and Therapeutics Market by Diagnostic Products (Dermatoscopes, Imaging, Microscopes, and Trichoscopes), Therapeutic Products (Antibacterial, Antifungal, Antiviral, Biological, Corticosteroids, Immunosuppressant, and Retinoids) and Product Pipeline (Clinical Phase 1, 2 and 3) and Forecast 2017-2021

Diagnosis and treatment of skin abnormalities and diseases covers both medical and surgical aspects dealing with the skin, nails, hair and its diseases along with various topical therapies for specific skin diseases such as dermatitis, warts, and tumors. Dermatology diagnostics and therapeutics mainly include chronic and acute skin diseases such as acne, rosacea, psoriasis, squamous cell carcinoma, eczema, dermatitis, and pruritus are major health concerns worldwide and account for a large portion of health care associated financial burden. The most common skin conditions are moles, chickenpox, acne, rashes, hives, eczema (atopic, allergic, or nummular dermatitis), skin cancer, rosacea, seborrheic dermatitis (causing cradle cap or dandruff), psoriasis, vitiligo, impetigo, and warts.

The global dermatology diagnostics and therapeutics market report estimates the market size (Revenue USD million – 2014 to 2021) for market segmentation based on diagnostic products (dermatoscopes, imaging, microscopes, and trichoscopes), therapeutic products (antibacterial, antifungal, antiviral, biological, corticosteroids, immunosuppressant, and retinoids) and their product pipeline (clinical phase 1, 2 and 3) and forecasts growth trends (CAGR% – 2017 to 2021).

The global dermatology diagnostics and therapeutics market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global dermatology diagnostics and therapeutics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global dermatology diagnostics and therapeutics market and included in this report are Agfa HealthCare NV, Astellas Pharma US, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech Inc., GlaxoSmithKline plc, LEO Pharma A/S, Michelson Diagnostics Limited, Novartis AG, Valeant Pharmaceuticals International, Inc.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Diagnostic Test Type
    • Indication or Infection Type
    • Technology
    • Diagnostics Application
    • Service Type
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Dermatology Diagnostics and Therapeutics Market

1. Diagnostic Product
1.1. Dermatoscopes
1.2. Imaging Equipment
1.3. Microscopes and Trichoscopes

2. Therapeutic Product (Drug Class)
2.1. Antibacterials
2.2. Antifungal Agents
2.3. Antiviral Agents
2.4. Biologics
2.5. Corticosteroids
2.6. Immunosuppresants
2.7. Retinoids

3. Product Pipeline Analysis
3.1. Phase 1 and Phase 2 Candidates
3.2. Phase 3 Candidates
3.2.1. CD5789
3.2.2. Dupilumab
3.2.3. IDP-118
3.2.4. Ixekizumab
3.2.5. LAS41008

4. Company Profiles
4.1. Agfa-Gevaert N.V.
4.2. Astellas Pharma, Inc.
4.3. Cutera, Inc.
4.4. Dino-Lite Europe/IDCP B.V.
4.5. Galderma S.A.
4.6. Genentech (Roche)
4.7. GlaxoSmithKline plc (Stiefel Laboratories, Inc.)
4.8. LEO Pharma A/S
4.9. Michelson Diagnostics Ltd.
4.10. Novartis International AG
4.11. Valeant Pharmaceuticals International, Inc.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*